This inventor holds 3 USPTO granted patents. Top assignee: Virginia Tech Intellectual Properties Inc.. Active years: 1991-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Blacksburg, VA (US) (1991 - 1994)
- Kalamazoo, MI (US) (1994)
Company Filing History:
Years Active: 1991-1994
Title: Zhi-Yang Zhao: Innovator in Water Soluble Taxol Derivatives
Introduction
Zhi-Yang Zhao is a prominent inventor based in Blacksburg, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of water-soluble derivatives of taxol. With a total of 3 patents to his name, Zhao's work has the potential to enhance the efficacy of cancer treatments.
Latest Patents
Zhao's latest patents focus on the synthesis of sulfonated 2'-acryloyltaxol and sulfonated 2'-O-acyl acid taxol derivatives. These compounds exhibit improved water solubility and stability while maintaining bioactivity. Notably, he synthesized 2'-[(3-sulfo-1-oxopropyl)oxy]taxol sodium salt by reacting taxol with acrylic acid, followed by a Michael reaction with bisulfite. Additionally, he developed 2'-{[4-((2-sulfoethyl)amino)-1,4-dioxobutyl]oxy}taxol sodium salt and 2'-{[4-((3-sulfopropyl)amino)-1,4-dioxobutyl]oxy}taxol sodium salt through reactions involving 2'-succinyltaxol and tetrabutylammonium salts. Furthermore, glycol derivatives of 2'-O-acyl acid taxols were synthesized to enhance water solubility.
Career Highlights
Zhi-Yang Zhao is affiliated with Virginia Tech Intellectual Properties Inc., where he continues to innovate in the field of pharmaceutical chemistry. His research has garnered attention for its potential applications in improving drug delivery systems.
Collaborations
Zhao collaborates with David G Kingston, a fellow researcher, to further advance their work in the synthesis of pharmaceutical compounds.
Conclusion
Zhi-Yang Zhao's contributions to the development of water-soluble taxol derivatives represent a significant advancement in cancer treatment. His innovative approach and collaborative efforts continue to pave the way for future breakthroughs in pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
